Acclivity Technologies, Inc. (ATI) is a discovery to preclinical health technologies company located in North Carolina. ATI’s lead drug candidate, ATI-0019, is a novel small molecule for a known atherosclerotic and ischemic disease target not previously known to be druggable by small molecules. Activation of this target reverses cardiovascular disease driver processes, including endothelial dysfunction, endothelial damage and loss of vasculature, inflammatory cell response, smooth muscle cell proliferation and migration, and platelet activation. We are testing and improving the pharmacological properties of ATI-0019, building a library of related compounds, and conducting in vitro and in vivo studies to establish the utility of ATI-0019 to treat our lead disease indication, peripheral artery disease, and its manifestations including intermittent claudication, critical limb ischemia, non-healing wounds, and diabetic foot. ATI-0019 and its derivatives will serve as the foundation for pipeline expansion to include other cardiovascular, inflammatory and ischemic disease indications, vasculitis, and type 2 diabetes. At ATI, we envision future technology development to include drug/device and diagnostic applications.
Contact Us: info@acclivitytechnologies.com
Company Details
- Employees
- 2
- Founded
- -
- Address
- Raleigh, Nc, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Los Angeles.
- HQ
- Raleigh, NC
Acclivity Technologies, Inc. Questions
Acclivity Technologies, Inc.'s website is http://www.acclivitytechnologies.com
Acclivity Technologies, Inc.'s LinkedIn profile is https://www.linkedin.com/company/acclivity-technologies-inc
Acclivity Technologies, Inc. has
2 employees.
View email and phone details for 2
employees at Acclivity Technologies, Inc..
Acclivity Technologies, Inc.'s industry is
Biotechnology Research
Acclivity Technologies, Inc.'s top competitors are
Activon, Inc.,
Albertsons Osco Drug,
Accessamed,
Aesthetic Oral Arts,
Pacific Heart, Lung & Blood Institute,
Airja, Inc.,
Milx Technologies,
Acorn Nmr,
Advanced Pharmaceutical Sciences Inc.,
Advantage Pharmaceuticals.
Acclivity Technologies, Inc.'s categories are Biotechnology Research
Acclivity Technologies, Inc.'s founding year is 2022
